Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance-Related Disorders | 10 | 2015 | 1019 | 1.430 |
Why?
|
| Gray Matter | 4 | 2019 | 79 | 1.320 |
Why?
|
| Alcoholism | 7 | 2018 | 759 | 1.200 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2019 | 3348 | 1.110 |
Why?
|
| Risk-Taking | 10 | 2018 | 344 | 1.100 |
Why?
|
| Executive Function | 6 | 2021 | 420 | 1.080 |
Why?
|
| Adolescent Behavior | 8 | 2019 | 498 | 1.070 |
Why?
|
| Brain | 12 | 2019 | 2592 | 0.940 |
Why?
|
| Alcohol Drinking | 7 | 2019 | 742 | 0.840 |
Why?
|
| Neuroimaging | 2 | 2017 | 273 | 0.830 |
Why?
|
| Sexual Behavior | 5 | 2018 | 453 | 0.720 |
Why?
|
| Reward | 4 | 2018 | 238 | 0.710 |
Why?
|
| Marijuana Smoking | 4 | 2019 | 240 | 0.700 |
Why?
|
| White Matter | 2 | 2019 | 127 | 0.670 |
Why?
|
| Tobacco Use | 1 | 2019 | 59 | 0.630 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 328 | 0.600 |
Why?
|
| Marijuana Use | 2 | 2019 | 192 | 0.600 |
Why?
|
| Parietal Lobe | 2 | 2015 | 47 | 0.590 |
Why?
|
| Marijuana Abuse | 2 | 2017 | 230 | 0.550 |
Why?
|
| Cerebral Cortex | 2 | 2018 | 407 | 0.520 |
Why?
|
| Alcohol-Related Disorders | 2 | 2013 | 114 | 0.500 |
Why?
|
| Temporal Lobe | 1 | 2015 | 83 | 0.480 |
Why?
|
| Craving | 1 | 2015 | 39 | 0.470 |
Why?
|
| Cannabis | 1 | 2021 | 438 | 0.460 |
Why?
|
| Telemedicine | 1 | 2023 | 773 | 0.460 |
Why?
|
| Psychotherapy | 1 | 2015 | 162 | 0.440 |
Why?
|
| Juvenile Delinquency | 1 | 2013 | 108 | 0.410 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2014 | 146 | 0.380 |
Why?
|
| Sex Characteristics | 2 | 2016 | 722 | 0.370 |
Why?
|
| Adolescent | 22 | 2019 | 20197 | 0.370 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2013 | 171 | 0.360 |
Why?
|
| Organ Size | 3 | 2017 | 446 | 0.350 |
Why?
|
| Text Messaging | 1 | 2012 | 146 | 0.330 |
Why?
|
| Self Report | 3 | 2013 | 796 | 0.320 |
Why?
|
| Aging | 3 | 2016 | 1767 | 0.320 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2013 | 42 | 0.290 |
Why?
|
| Limbic System | 2 | 2018 | 46 | 0.240 |
Why?
|
| Humans | 32 | 2023 | 128896 | 0.240 |
Why?
|
| Pilot Projects | 2 | 2021 | 1545 | 0.240 |
Why?
|
| Adolescent Development | 2 | 2018 | 82 | 0.230 |
Why?
|
| Male | 25 | 2019 | 63146 | 0.230 |
Why?
|
| Female | 25 | 2019 | 68162 | 0.220 |
Why?
|
| Nerve Net | 2 | 2018 | 249 | 0.210 |
Why?
|
| Cognition | 2 | 2021 | 1093 | 0.200 |
Why?
|
| Young Adult | 14 | 2018 | 12286 | 0.190 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2013 | 68 | 0.180 |
Why?
|
| Prefrontal Cortex | 2 | 2015 | 293 | 0.180 |
Why?
|
| Longitudinal Studies | 5 | 2014 | 2668 | 0.180 |
Why?
|
| Memory Disorders | 1 | 2021 | 156 | 0.170 |
Why?
|
| Condoms | 3 | 2018 | 102 | 0.170 |
Why?
|
| Underage Drinking | 1 | 2019 | 20 | 0.160 |
Why?
|
| Feasibility Studies | 1 | 2023 | 859 | 0.160 |
Why?
|
| Puberty | 2 | 2018 | 143 | 0.160 |
Why?
|
| Memory, Short-Term | 1 | 2021 | 255 | 0.160 |
Why?
|
| Safe Sex | 1 | 2018 | 20 | 0.150 |
Why?
|
| Brain Mapping | 3 | 2018 | 562 | 0.150 |
Why?
|
| Delay Discounting | 1 | 2018 | 18 | 0.150 |
Why?
|
| Aged | 3 | 2023 | 22035 | 0.150 |
Why?
|
| Southwestern United States | 1 | 2017 | 91 | 0.140 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2018 | 90 | 0.140 |
Why?
|
| Functional Neuroimaging | 2 | 2015 | 73 | 0.140 |
Why?
|
| Corpus Striatum | 1 | 2018 | 153 | 0.130 |
Why?
|
| Middle Aged | 8 | 2019 | 30977 | 0.130 |
Why?
|
| Anisotropy | 2 | 2013 | 69 | 0.130 |
Why?
|
| Cognitive Neuroscience | 1 | 2016 | 10 | 0.130 |
Why?
|
| Linear Models | 2 | 2016 | 817 | 0.130 |
Why?
|
| Surveys and Questionnaires | 5 | 2016 | 5355 | 0.130 |
Why?
|
| Cues | 2 | 2018 | 319 | 0.120 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2017 | 294 | 0.120 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2012 | 94 | 0.120 |
Why?
|
| Gyrus Cinguli | 1 | 2015 | 78 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2016 | 739 | 0.120 |
Why?
|
| Task Performance and Analysis | 1 | 2015 | 174 | 0.110 |
Why?
|
| Drug Users | 1 | 2014 | 44 | 0.110 |
Why?
|
| Cerebrum | 1 | 2013 | 7 | 0.110 |
Why?
|
| Retinal Dehydrogenase | 1 | 2013 | 33 | 0.110 |
Why?
|
| Taste Perception | 1 | 2013 | 23 | 0.110 |
Why?
|
| Sex Factors | 1 | 2019 | 1947 | 0.110 |
Why?
|
| Binge Drinking | 1 | 2012 | 34 | 0.100 |
Why?
|
| Self-Evaluation Programs | 1 | 2012 | 6 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2013 | 479 | 0.100 |
Why?
|
| Intention | 1 | 2013 | 158 | 0.100 |
Why?
|
| Self Efficacy | 1 | 2015 | 377 | 0.100 |
Why?
|
| Self-Assessment | 1 | 2012 | 70 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 5032 | 0.090 |
Why?
|
| Adult | 8 | 2018 | 35361 | 0.090 |
Why?
|
| Radiography | 1 | 2014 | 863 | 0.090 |
Why?
|
| Cerebellum | 1 | 2012 | 216 | 0.090 |
Why?
|
| Neural Pathways | 1 | 2012 | 288 | 0.090 |
Why?
|
| Ethanol | 1 | 2012 | 577 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 2767 | 0.070 |
Why?
|
| Smoking | 1 | 2015 | 1501 | 0.070 |
Why?
|
| Risk Factors | 4 | 2013 | 9792 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 7050 | 0.070 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 4917 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2013 | 10239 | 0.050 |
Why?
|
| Exercise | 1 | 2013 | 1923 | 0.050 |
Why?
|
| HIV Infections | 1 | 2016 | 2696 | 0.050 |
Why?
|
| DNA Methylation | 2 | 2018 | 600 | 0.040 |
Why?
|
| Decision Making | 2 | 2018 | 837 | 0.040 |
Why?
|
| Methylation | 1 | 2017 | 227 | 0.030 |
Why?
|
| Taste | 1 | 2018 | 214 | 0.030 |
Why?
|
| Unsafe Sex | 1 | 2016 | 55 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 424 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2014 | 133 | 0.030 |
Why?
|
| Animals | 1 | 2015 | 34628 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 1194 | 0.030 |
Why?
|
| CpG Islands | 1 | 2013 | 151 | 0.030 |
Why?
|
| Neuroanatomy | 1 | 2012 | 10 | 0.020 |
Why?
|
| Neuropsychology | 1 | 2012 | 33 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2012 | 146 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 2010 | 25 | 0.020 |
Why?
|
| Forecasting | 1 | 2012 | 363 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1968 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1283 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 336 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2015 | 14546 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 3133 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2010 | 994 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 3059 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 1264 | 0.010 |
Why?
|
| Mental Health | 1 | 2010 | 675 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6568 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 7060 | 0.010 |
Why?
|
| United States | 1 | 2013 | 13975 | 0.010 |
Why?
|
| Child | 1 | 2010 | 20824 | 0.010 |
Why?
|